We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STLD icon
326
Steel Dynamics
STLD
$37.9B
$49K 0.06%
+1,861
New +$46.5K
VER
327
DELISTED
VEREIT, Inc.
VER
$48K 0.06%
+1,508
New +$42K
CTAS icon
328
Cintas
CTAS
$82.4B
$47K 0.05%
708
-8,744
-93% -$506K
XOM icon
329
ExxonMobil
XOM
$657B
$47K 0.05%
1,061
+536
+102% +$24K
FOLD
330
DELISTED
Amicus Therapeutics
FOLD
$46K 0.05%
3,072
-12,423
-80% -$151K
IQV icon
331
IQVIA
IQV
$40.2B
$46K 0.05%
327
-1,757
-84% -$238K
LULU icon
332
lululemon athletica
LULU
$14.3B
$46K 0.05%
149
-1,635
-92% -$418K
HAE icon
333
Haemonetics
HAE
$3.98B
$44K 0.05%
487
+2
+0.4% +$202
KHC icon
334
Kraft Heinz
KHC
$29.3B
$44K 0.05%
+1,395
New +$41.9K
PPG icon
335
PPG Industries
PPG
$25.8B
$43K 0.05%
404
+195
+93% +$18.8K
UAL icon
336
United Airlines
UAL
$41.1B
$43K 0.05%
+1,229
New +$36.9K
ZWS icon
337
Zurn Elkay Water Solutions
ZWS
$8.59B
$42K 0.05%
2,960
-16,841
-85% -$221K
VG
338
DELISTED
Vonage Holdings Corporation
VG
$42K 0.05%
+4,169
New +$37.4K
ALB icon
339
Albemarle
ALB
$15.2B
$41K 0.05%
528
-831
-61% -$56.5K
EPR icon
340
EPR Properties
EPR
$4.61B
$41K 0.05%
+1,224
New +$36.3K
NVDA icon
341
NVIDIA
NVDA
$5.26T
$41K 0.05%
4,280
-27,400
-86% -$222K
HBI
342
DELISTED
Hanesbrands
HBI
$40K 0.05%
3,534
-30,627
-90% -$306K
MSM icon
343
MSC Industrial Direct
MSM
$6.74B
$40K 0.05%
552
-326
-37% -$21K
FSLR icon
344
First Solar
FSLR
$25.9B
$39K 0.04%
+778
New +$34.7K
UNM icon
345
Unum
UNM
$14.3B
$39K 0.04%
2,327
-1,966
-46% -$31K
MO icon
346
Altria Group
MO
$108B
$38K 0.04%
+979
New +$38.2K
TRGP icon
347
Targa Resources
TRGP
$57B
$38K 0.04%
+1,885
New +$28.3K
GAP
348
The Gap Inc
GAP
$7.57B
$38K 0.04%
+2,983
New +$26.9K
AGNC icon
349
AGNC Investment
AGNC
$12.9B
$37K 0.04%
2,856
-21,181
-88% -$266K
MPC icon
350
Marathon Petroleum
MPC
$94.1B
$37K 0.04%
977
-3,489
-78% -$112K

Similar funds

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.